These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32405042)

  • 1. Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease.
    Mallapaty S
    Nature; 2020 May; 581(7808):249-250. PubMed ID: 32405042
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Reprogrammed' stem cells approved to mend human hearts for the first time.
    Cyranoski D
    Nature; 2018 May; 557(7707):619-620. PubMed ID: 29844563
    [No Abstract]   [Full Text] [Related]  

  • 3. Japan must tighten up clinical trial of stem cells for heart failure.
    Akabayashi A; Nakazawa E; Jecker NS
    Nature; 2018 Aug; 560(7719):431. PubMed ID: 30135533
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac stem cell therapy: progress from the bench to bedside.
    Lovell MJ; Mathur A
    Heart; 2010 Oct; 96(19):1531-7. PubMed ID: 20668107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Translational research of cell sheet-based myocardial regeneration therapy].
    Miyagawa S
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):269-71. PubMed ID: 27181720
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac cell therapy: the next (re)generation.
    Forte E; Chimenti I; Barile L; Gaetani R; Angelini F; Ionta V; Messina E; Giacomello A
    Stem Cell Rev Rep; 2011 Nov; 7(4):1018-30. PubMed ID: 21437575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac stem cell therapy and the promise of heart regeneration.
    Garbern JC; Lee RT
    Cell Stem Cell; 2013 Jun; 12(6):689-98. PubMed ID: 23746978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair.
    Peng H; Shindo K; Donahue RR; Abdel-Latif A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
    Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
    Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells and their potential in cell-based cardiac therapies.
    Christoforou N; Gearhart JD
    Prog Cardiovasc Dis; 2007; 49(6):396-413. PubMed ID: 17498520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac cell therapy: lessons from clinical trials.
    Menasche P
    J Mol Cell Cardiol; 2011 Feb; 50(2):258-65. PubMed ID: 20600097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell transplantation for heart disease: the clinical perspective.
    Yang S; Fazel S; Angoulvant D; Weisel RD; Li RK
    Evid Based Cardiovasc Med; 2005 Mar; 9(1):2-7. PubMed ID: 16379977
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.
    Rikhtegar R; Pezeshkian M; Dolati S; Safaie N; Afrasiabi Rad A; Mahdipour M; Nouri M; Jodati AR; Yousefi M
    Biomed Pharmacother; 2019 Jan; 109():304-313. PubMed ID: 30396088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts.
    Zhang Y; Cao N; Huang Y; Spencer CI; Fu JD; Yu C; Liu K; Nie B; Xu T; Li K; Xu S; Bruneau BG; Srivastava D; Ding S
    Cell Stem Cell; 2016 Mar; 18(3):368-81. PubMed ID: 26942852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells and cardiac disorders: an appraisal.
    Goldenthal MJ; Marín-García J
    Cardiovasc Res; 2003 May; 58(2):369-77. PubMed ID: 12757871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing vascularized heart tissue from stem cells.
    Lim SY; Hernández D; Dusting GJ
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):122-9. PubMed ID: 23924689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.
    Lyon AR; Harding SE; Peters NS
    J Cardiovasc Transl Res; 2008 Sep; 1(3):207-16. PubMed ID: 20559921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.
    Zhu K; Wu Q; Ni C; Zhang P; Zhong Z; Wu Y; Wang Y; Xu Y; Kong M; Cheng H; Tao Z; Yang Q; Liang H; Jiang Y; Li Q; Zhao J; Huang J; Zhang F; Chen Q; Li Y; Chen J; Zhu W; Yu H; Zhang J; Yang HT; Hu X; Wang J
    Circ Res; 2018 Mar; 122(7):958-969. PubMed ID: 29343525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.